ProfileGDS4718 / 1557034_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 47% 53% 44% 50% 46% 52% 49% 51% 46% 49% 56% 50% 57% 48% 47% 54% 47% 49% 44% 54% 48% 57% 39% 37% 50% 43% 44% 51% 43% 53% 45% 52% 55% 54% 46% 39% 49% 51% 56% 44% 44% 53% 47% 52% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3540947
GSM549102patient 115, normal, homogenized [OPG study]5.7378553
GSM549104patient 119, normal, homogenized [OPG study]5.2007444
GSM549108patient 138, normal, homogenized [OPG study]5.5772550
GSM549119patient 077, normal, homogenized [OPG study]5.2826946
GSM549133patient 032, cancer, homogenized [OPG study]5.564852
GSM549139patient 042, cancer, homogenized [OPG study]5.4390149
GSM549099patient 107, normal, homogenized [OPG study]5.5831551
GSM549109patient 139, normal, homogenized [OPG study]5.3371246
GSM549110patient 046, normal, homogenized [OPG study]5.4418849
GSM549114patient 063, normal, homogenized [OPG study]5.815456
GSM549122patient 082, normal, homogenized [OPG study]5.4919750
GSM549134patient 033, cancer, homogenized [OPG study]5.881757
GSM549136patient 036, cancer, homogenized [OPG study]5.3346748
GSM549140patient 044, cancer, homogenized [OPG study]5.3390747
GSM549111patient 047, normal, homogenized [OPG study]5.7539954
GSM549113patient 057, normal, homogenized [OPG study]5.3099447
GSM549132patient 031, cancer, homogenized [OPG study]5.4255649
GSM549137patient 038, cancer, homogenized [OPG study]5.1890244
GSM549142patient 047, cancer, homogenized [OPG study]5.8738654
GSM549100patient 110, normal, homogenized [OPG study]5.4129848
GSM549107patient 135, normal, homogenized [OPG study]5.8955257
GSM549115patient 068, normal, homogenized [OPG study]4.8688639
GSM549116patient 072, normal, homogenized [OPG study]4.8248937
GSM549120patient 078, normal, homogenized [OPG study]5.4987150
GSM549131patient 030, cancer, homogenized [OPG study]5.0855343
GSM549118patient 074, normal, homogenized [OPG study]5.1599344
GSM549129patient 027, cancer, homogenized [OPG study]5.577251
GSM549123patient 088, normal, homogenized [OPG study]5.1058443
GSM549124patient 006, cancer, homogenized [OPG study]5.7035853
GSM549126patient 015, cancer, homogenized [OPG study]5.2119445
GSM549128patient 025, cancer, homogenized [OPG study]5.6034752
GSM549103patient 117, normal, homogenized [OPG study]5.8486955
GSM549117patient 073, normal, homogenized [OPG study]5.7205554
GSM549138patient 041, cancer, homogenized [OPG study]5.2875346
GSM549141patient 045, cancer, homogenized [OPG study]4.8691339
GSM549130patient 028, cancer, homogenized [OPG study]5.4504949
GSM549101patient 111, normal, homogenized [OPG study]5.6068351
GSM549105patient 128, normal, homogenized [OPG study]5.8975356
GSM549106patient 134, normal, homogenized [OPG study]5.1445344
GSM549112patient 048, normal, homogenized [OPG study]5.1602344
GSM549125patient 011, cancer, homogenized [OPG study]5.6904453
GSM549127patient 024, cancer, homogenized [OPG study]5.3614647
GSM549135patient 035, cancer, homogenized [OPG study]5.6049652